Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2020

02.12.2019 | Original Research

Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty

verfasst von: Mara A. G. Hollander, B.A., Julie M. Donohue, PhD, Bradley D. Stein, MD, PhD, Elizabeth E. Krans, MD, MSc, Marian P. Jarlenski, PhD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The association between pharmaceutical industry promotion and physician opioid prescribing is poorly understood. Whether the influence of industry gifts on prescribing varies by specialty is unknown.

Objective

To examine the relationship between opioid-related gifts to physicians and opioid prescribing in the subsequent year across 7 physician specialties.

Design

Panel study using data from 2014 to 2016.

Participants

236,103 unique Medicare Part D physicians (389,622 physician-years) who received any gifts from pharmaceutical companies measured using Open Payments and prescribed opioids in the subsequent year.

Main Measures

Amounts paid by pharmaceutical companies for opioid-related gifts including meals and lodging; quartile of opioid prescribing as a percent of total prescribing compared with other same-specialty physicians.

Key Results

In 2014–2015, 14.1% of physician received opioid-related gifts from the industry with 2.6% receiving > $100. Gifts varied by specialty and were concentrated among two pharmaceutical companies responsible for 60% of the value of opioid-related gifts. Receiving opioid-related gifts was associated with greater prescribing of opioids compared with same-specialty physicians in the next year. Primary care physicians are nearly 3.5 times as likely to be in the highest quartile of prescribing versus the lower quartiles if they were paid ≥ $100. Psychiatrists and neurologists were 7 to 13 times as likely to be in a higher quartile of opioid prescribing compared with colleagues who were paid $0 in the preceding year.

Conclusions

The value of opioid-related gifts given to physicians varies substantially by provider specialty, as does the relationship between payment amounts and prescriber behavior in the following year.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016;315(15):1624-45.CrossRef Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016;315(15):1624-45.CrossRef
3.
Zurück zum Zitat Hadland SE, Cerda M, Li Y, Krieger MS, Marshall BDL. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. JAMA Intern Med 2018;178(6):861-3.CrossRef Hadland SE, Cerda M, Li Y, Krieger MS, Marshall BDL. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing. JAMA Intern Med 2018;178(6):861-3.CrossRef
4.
Zurück zum Zitat Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerda M. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses. JAMA Netw Open 2019;2(1):e186007.CrossRef Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerda M. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses. JAMA Netw Open 2019;2(1):e186007.CrossRef
5.
Zurück zum Zitat Hadland SE, Krieger MS, Marshall BDL. Industry Payments to Physicians for Opioid Products, 2013-2015. Am J Public Health 2017;107(9):1493-5.CrossRef Hadland SE, Krieger MS, Marshall BDL. Industry Payments to Physicians for Opioid Products, 2013-2015. Am J Public Health 2017;107(9):1493-5.CrossRef
6.
Zurück zum Zitat Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR, et al. A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998;13(3):151-4.CrossRef Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR, et al. A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998;13(3):151-4.CrossRef
7.
Zurück zum Zitat Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 1996;5(4):201-6.CrossRef Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 1996;5(4):201-6.CrossRef
8.
Zurück zum Zitat Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252-5.CrossRef Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252-5.CrossRef
9.
Zurück zum Zitat Babcock L, Loewenstein G, Issacharoff S. Creating Convergence: Debiasing Biased Litigants. Law Soc Inq 1997;22(4):913-25.CrossRef Babcock L, Loewenstein G, Issacharoff S. Creating Convergence: Debiasing Biased Litigants. Law Soc Inq 1997;22(4):913-25.CrossRef
10.
Zurück zum Zitat Emanuel G, Thomas K. Top Executives of Insys, an Opioid Company, Are Found Guilty of Racketeering. The New York Times. New York. Emanuel G, Thomas K. Top Executives of Insys, an Opioid Company, Are Found Guilty of Racketeering. The New York Times. New York.
11.
Zurück zum Zitat Dolmetsch C. Purdue’s Sackler Family Must Face Opioid Suits in New York. Bloomberg. New York. Dolmetsch C. Purdue’s Sackler Family Must Face Opioid Suits in New York. Bloomberg. New York.
12.
Zurück zum Zitat Hoffman J. Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit. The New York Times, New York. Hoffman J. Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid Lawsuit. The New York Times, New York.
13.
Zurück zum Zitat Opioid Manufacturer Insys Therapeutics Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations. Company Admits Illegal Conduct Regarding Promotion of Subsys, a Powerful Opioid Painkiller. 19-621 ed: Department of Justice Office of Public Affairs; 2019. Opioid Manufacturer Insys Therapeutics Agrees to Enter $225 Million Global Resolution of Criminal and Civil Investigations. Company Admits Illegal Conduct Regarding Promotion of Subsys, a Powerful Opioid Painkiller. 19-621 ed: Department of Justice Office of Public Affairs; 2019.
14.
Zurück zum Zitat Magnus SA. Physicians’ financial incentives in five dimensions: a conceptual framework for HMO managers. Health Care Manag Rev 1999;24(1):57-72. Magnus SA. Physicians’ financial incentives in five dimensions: a conceptual framework for HMO managers. Health Care Manag Rev 1999;24(1):57-72.
15.
Zurück zum Zitat Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012 Am J Prev Med 2015;49(3):409-13.CrossRef Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007-2012 Am J Prev Med 2015;49(3):409-13.CrossRef
20.
Zurück zum Zitat Opioids: Brand names, generic names & street names. It Matters Colorado. Opioids: Brand names, generic names & street names. It Matters Colorado.
25.
Zurück zum Zitat Tigas M, Jones RG, Ornstein C, Groeger L. Dollars for Docs NPI/Open Payments Crosswalk. Tigas M, Jones RG, Ornstein C, Groeger L. Dollars for Docs NPI/Open Payments Crosswalk.
26.
Zurück zum Zitat Jones RG, Ornstein C. Matching Industry Payments to Medicare Prescribing Patterns: An Analysis. ProPublica, Manhattan; 2016. Jones RG, Ornstein C. Matching Industry Payments to Medicare Prescribing Patterns: An Analysis. ProPublica, Manhattan; 2016.
27.
Zurück zum Zitat DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med 2016;176(8):1114-22.CrossRef DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med 2016;176(8):1114-22.CrossRef
28.
Zurück zum Zitat PhRMA. Code on Interactions with Healthcare Professionals. 2008. PhRMA. Code on Interactions with Healthcare Professionals. 2008.
29.
Zurück zum Zitat Williams R. Generalized ordered logit/partial proportional odds models for ordinal dependent variables. Stata J 2006;6(1):58-82.CrossRef Williams R. Generalized ordered logit/partial proportional odds models for ordinal dependent variables. Stata J 2006;6(1):58-82.CrossRef
30.
Zurück zum Zitat Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt 2014;34(5):502-8.CrossRef Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt 2014;34(5):502-8.CrossRef
32.
Zurück zum Zitat Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, et al. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. BMJ 2016;354. Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, et al. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. BMJ 2016;354.
33.
Zurück zum Zitat Lo B, Grady D. Payments to Physicians: Does the Amount of Money Make a Difference? JAMA. 2017;317(17). Lo B, Grady D. Payments to Physicians: Does the Amount of Money Make a Difference? JAMA. 2017;317(17).
34.
Zurück zum Zitat Wood SF, Podrasky J, McMonagle MA, Raveendran J, Bysshe T, Hogenmiller A, et al. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia. PLoS One 2017;12(10):e0186060.CrossRef Wood SF, Podrasky J, McMonagle MA, Raveendran J, Bysshe T, Hogenmiller A, et al. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia. PLoS One 2017;12(10):e0186060.CrossRef
35.
Zurück zum Zitat Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. JAMA Intern Med 2016;176(6):763-8.CrossRef Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. JAMA Intern Med 2016;176(6):763-8.CrossRef
36.
Zurück zum Zitat Dufour R, Joshi AV, Pasquale MK, Schaaf D, Mardekian J, Andrews GA, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract 2014;14(3):E106-15.CrossRef Dufour R, Joshi AV, Pasquale MK, Schaaf D, Mardekian J, Andrews GA, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Pain Pract 2014;14(3):E106-15.CrossRef
37.
Zurück zum Zitat Anderson KK, Hendrick F, McClair V. National Trends in High-dose Chronic Opioid Utilization among Dually Eligible and Medicare-only Beneficiaries (2006-2015). Data Analysis Brief: Center for Medicare and Medicaid Services; 2018. Anderson KK, Hendrick F, McClair V. National Trends in High-dose Chronic Opioid Utilization among Dually Eligible and Medicare-only Beneficiaries (2006-2015). Data Analysis Brief: Center for Medicare and Medicaid Services; 2018.
38.
Zurück zum Zitat Meara E, Horwitz JR, Powell W, McClelland L, Zhou W, O’Malley AJ, et al. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. N Engl J Med 2016;375(1):44-53.CrossRef Meara E, Horwitz JR, Powell W, McClelland L, Zhou W, O’Malley AJ, et al. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. N Engl J Med 2016;375(1):44-53.CrossRef
39.
Zurück zum Zitat Carey CM, Jena AB, Barnett ML. Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012. Ann Intern Med 2018;168(12):837-45.CrossRef Carey CM, Jena AB, Barnett ML. Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012. Ann Intern Med 2018;168(12):837-45.CrossRef
40.
Zurück zum Zitat Boccuti C, Swoope C, Damico A, Neuman T. Medicare Patients’ Access to Physicians: A Synthesis of the Evidence. Kaiser Family Foundation, San Francisco; 2013. Boccuti C, Swoope C, Damico A, Neuman T. Medicare Patients’ Access to Physicians: A Synthesis of the Evidence. Kaiser Family Foundation, San Francisco; 2013.
41.
Zurück zum Zitat Tringale KR, Marshall D, Mackey TK, Connor M, Murphy JD, Hattangadi-Gluth JA. Types and Distribution of Payments From Industry to Physicians in 2015. JAMA. 2017;317(17):1774-84.CrossRef Tringale KR, Marshall D, Mackey TK, Connor M, Murphy JD, Hattangadi-Gluth JA. Types and Distribution of Payments From Industry to Physicians in 2015. JAMA. 2017;317(17):1774-84.CrossRef
42.
Zurück zum Zitat Cialdini RB. Influence: The Psychology of Persuasion: Harper Business; 1993. Cialdini RB. Influence: The Psychology of Persuasion: Harper Business; 1993.
43.
Zurück zum Zitat Katz D, Caplan AL, Merz JF. All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift Giving. Am J Bioeth 2003;3(3):39-46.CrossRef Katz D, Caplan AL, Merz JF. All Gifts Large and Small: Toward an Understanding of the Ethics of Pharmaceutical Industry Gift Giving. Am J Bioeth 2003;3(3):39-46.CrossRef
44.
Zurück zum Zitat Manchanda P, Xie Y, Youn N. The Role of Targeted Communication and Contagion in Product Adoption. Mark Sci 2008;27(6):961-76.CrossRef Manchanda P, Xie Y, Youn N. The Role of Targeted Communication and Contagion in Product Adoption. Mark Sci 2008;27(6):961-76.CrossRef
45.
Zurück zum Zitat Commercial Access to Physicians: Medical Industry Sales Reps Accessibility to U.S. Physicians. Irvine, CA: SK&A; 2017. Commercial Access to Physicians: Medical Industry Sales Reps Accessibility to U.S. Physicians. Irvine, CA: SK&A; 2017.
46.
Zurück zum Zitat Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, et al. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing. JAMA. 2017;317(17):1785-95.CrossRef Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, et al. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing. JAMA. 2017;317(17):1785-95.CrossRef
Metadaten
Titel
Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty
verfasst von
Mara A. G. Hollander, B.A.
Julie M. Donohue, PhD
Bradley D. Stein, MD, PhD
Elizabeth E. Krans, MD, MSc
Marian P. Jarlenski, PhD, MPH
Publikationsdatum
02.12.2019
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05470-0

Weitere Artikel der Ausgabe 8/2020

Journal of General Internal Medicine 8/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.